- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
- 10-Q Quarterly report
- 3.4 Restated Bylaws
- 3.5 Certificate of Third Amendment of Amended and Restated Certificate of Incorporation
- 10.18 Amendment, Dated March 10, 2000, to Amended and Restated Agreement Between Genentech and F. Hoffman-la Roche LTD Regarding Commercialization of Genentech's Products Outside the United States
- 10.19 Amendment, Dated June 26, 2000, to Amended and Restated Agreement Between Genentech and F. Hoffman-la Roche LTD Regarding Commercialization of Genentech's Products Outside the United States
- 10.20 Third Amendment, Dated April 30, 2004, to Amended and Restated Agreement Between Genentech and F. Hoffman-la Roche LTD Regarding Commercialization of Genentech's Products Outside the United States
- 10.21 Collaborative Agreement Among F. Hoffmann-la Roche LTD, Hoffmann-la Roche Inc. and Genentech, Dated April 13, 2004
- 15.1 Letter Regarding Unaudited Interim Financial Information
- 31.1 Certification of Chief Executive Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended
- 31.2 Certification of Chief Financial Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended
- 32.1 Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
EXHIBIT 15.1
July 26, 2004
The Board of Directors and Stockholders of Genentech, Inc.
We are aware of the incorporation by reference in the Registration Statements pertaining to the Genentech, Inc. Tax Reduction Investment Plan, the 2004 Equity Incentive Plan, the 1999 Stock Plan, the 1996 Stock Option/Stock Incentive Plan, the 1994 Stock Option Plan, the 1990 Stock Option/Stock Incentive Plan, and the 1991 Employee Stock Plan, and the Registration Statement (Form S-3 No. 333-37072) related to the resale of common shares deliverable upon the exchange of Liquid Yield Option Notes, and in the related Prospectuses, as applicable, contained in such Registration Statements of our report dated July 6, 2004, except for Note 11, as to which the date is July 23, 2004, relating to the unaudited condensed consolidated interim financial statements of Genentech, Inc. that are included in its Form 10-Q for the quarter ended June 30, 2004.
Pursuant to Rule 436(c) of the Securities Act of 1933 our report is not a part of the registration statement prepared or certified by accountants within the meaning of section 7 or 11 of the Securities Act of 1933.
Very truly yours, | ||
|